Business · 16/08/2022Updated: 10/17/2026 · 1 min read
AbbVie Inc., et al.; FDA Withdraws Approval of 30 New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of 30 new drug applications from multiple pharmaceutical companies, following written notifications that the drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →